» Articles » PMID: 26798439

Molecular Approach to Genetic and Epigenetic Pathogenesis of Early-onset Colorectal Cancer

Overview
Date 2016 Jan 23
PMID 26798439
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) is the third most frequent cancer type and the incidence of this disease is increasing gradually per year in individuals younger than 50 years old. The current knowledge is that early-onset CRC (EOCRC) cases are heterogeneous population that includes both hereditary and sporadic forms of the CRC. Although EOCRC cases have some distinguishing clinical and pathological features than elder age CRC, the molecular mechanism underlying the EOCRC is poorly clarified. Given the significance of CRC in the world of medicine, the present review will focus on the recent knowledge in the molecular basis of genetic and epigenetic mechanism of the hereditary forms of EOCRC, which includes Lynch syndrome, Familial CRC type X, Familial adenomatous polyposis, MutYH-associated polyposis, Juvenile polyposis syndrome, Peutz-Jeghers Syndrome and sporadic forms of EOCRC. Recent findings about molecular genetics and epigenetic basis of EOCRC gave rise to new alternative therapy protocols. Although exact diagnosis of these cases still remains complicated, the present review paves way for better predictions and contributes to more accurate diagnostic and therapeutic strategies into clinical approach.

Citing Articles

Early-Onset Colon Cancer: A Narrative Review of Its Pathogenesis, Clinical Presentation, Treatment, and Prognosis.

Lingas E Cureus. 2023; 15(9):e45404.

PMID: 37854763 PMC: 10579844. DOI: 10.7759/cureus.45404.


TCF7L2, CASC8, and GREM1 polymorphism and colorectal cancer in south-eastern Romanian population.

Mitroi A, Leopa N, Dumitru E, Dumitru A, Tocia C, Popescu I Medicine (Baltimore). 2023; 102(7):e33056.

PMID: 36800588 PMC: 9936048. DOI: 10.1097/MD.0000000000033056.


A GNAS Gene Mutation's Independent Expression in the Growth of Colorectal Cancer: A Systematic Review and Meta-Analysis.

Afolabi H, Salleh S, Zakaria Z, Chng E, Nafi S, Aziz A Cancers (Basel). 2022; 14(22).

PMID: 36428574 PMC: 9688108. DOI: 10.3390/cancers14225480.


Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer.

Ahmad Kendong S, Ali R, Muhammad Nawawi K, Ahmad H, Mokhtar N Front Cell Infect Microbiol. 2021; 11:744606.

PMID: 34966694 PMC: 8710575. DOI: 10.3389/fcimb.2021.744606.


Alpha-fetoprotein-producing recurrent nasopharyngeal carcinoma: A case report.

Yang Z, Luo M, Liu L, Cai M, Liang Y, Chen Q SAGE Open Med Case Rep. 2021; 9:2050313X211057704.

PMID: 34777811 PMC: 8573489. DOI: 10.1177/2050313X211057704.


References
1.
Jones S, Emmerson P, Maynard J, Best J, Jordan S, Williams G . Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C-->T:A mutations. Hum Mol Genet. 2002; 11(23):2961-7. DOI: 10.1093/hmg/11.23.2961. View

2.
French A, Sargent D, Burgart L, Foster N, Kabat B, Goldberg R . Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer. Clin Cancer Res. 2008; 14(11):3408-15. PMC: 2674786. DOI: 10.1158/1078-0432.CCR-07-1489. View

3.
Tougeron D, Fauquembergue E, Rouquette A, Le Pessot F, Sesboue R, Laurent M . Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations. Mod Pathol. 2009; 22(9):1186-95. DOI: 10.1038/modpathol.2009.80. View

4.
Loughrey M, Waring P, Tan A, Trivett M, Kovalenko S, Beshay V . Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Fam Cancer. 2007; 6(3):301-10. DOI: 10.1007/s10689-007-9124-1. View

5.
Hess G, Wang P, Quach D, Barber B, Zhao Z . Systemic Therapy for Metastatic Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in US Medical Oncology Practice. J Oncol Pract. 2011; 6(6):301-7. PMC: 2988664. DOI: 10.1200/JOP.2010.000072. View